Trials / Suspended
SuspendedNCT04199910
4beta-hydroxycholesterol in Cirrhosis
4beta-hydroksikolesteroli Maksakirroosissa
- Status
- Suspended
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- University of Oulu · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim is to evaluate the levels of oxysterols and especially 4beta-hydroxycholesterol in patients with liver cirrhosis. Three cirrhosis cohorts are recruited: patients treated with spironolactone, patients treated with rifaximin, patients without spironolactone or rifaximin. Also three other control cohorts are recruited: patients with pneumonia, patients with Crohn's disease, patients with ulcerative colitis. The effect of the cirrhosis and its medications spironolactone and rifaximin are compared to control groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | There is no intervention, only research blood samples are collected | Research blood samples collected |
Timeline
- Start date
- 2019-12-01
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2019-12-16
- Last updated
- 2024-05-08
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT04199910. Inclusion in this directory is not an endorsement.